Tryp Therapeutics Inc Ordinary Shares Stock (OTC:TRYPF), Quotes and News Summary

Tryp Therapeutics Inc Ordinary Shares Stock (OTC: TRYPF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 52.232K
Day Range	- - -
52 Wk Range	0.004 - 0.092
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing

Tryp Therapeutics finalizes merger with Exopharm, prepares for ASX listing with strategic shareholder benefits. Explore merger details now!

Patricio Liddle

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

Lara Goldstein

Tryp Therapeutics Explores Psilocybin's Potential In New Trials To Treat IBS And Fibromyalgia

Psychedelics biotech Tryp Therapeutics (OTCQB: TRYPF) is advancing its psilocybin-based portfolio through several recent milestones.

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tryp Therapeutics Inc Ordinary Shares (TRYPF) stock?

You can purchase shares of Tryp Therapeutics Inc Ordinary Shares (OTC: TRYPF) through any online brokerage.

View our list of the best stock brokerages.

Who are Tryp Therapeutics Inc Ordinary Shares's (TRYPF) competitors?

There are no as such competitors for Tryp Therapeutics Inc Ordinary Shares.

What is the target price for Tryp Therapeutics Inc Ordinary Shares (TRYPF) stock?

The latest price target for Tryp Therapeutics Inc Ordinary Shares (OTC: TRYPF) was reported by Ladenburg Thalmann on Thursday, January 5, 2023. The analyst firm set a price target for 1.50 expecting TRYPF to rise to within 12 months (a possible 2569.04% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Tryp Therapeutics Inc Ordinary Shares (TRYPF)?

The stock price for Tryp Therapeutics Inc Ordinary Shares (OTC: TRYPF) is $0.0562 last updated May 1, 2024 at 3:17 PM EDT.

Does Tryp Therapeutics Inc Ordinary Shares (TRYPF) pay a dividend?

There are no upcoming dividends for Tryp Therapeutics Inc Ordinary Shares.

When is Tryp Therapeutics Inc Ordinary Shares (OTC:TRYPF) reporting earnings?

Tryp Therapeutics Inc Ordinary Shares does not have any upcoming earnings scheduled.

Is Tryp Therapeutics Inc Ordinary Shares (TRYPF) going to split?

There is no upcoming split for Tryp Therapeutics Inc Ordinary Shares.